Tag: biologic drug switch

Switching from an originator biologic to a biosimilar is safe for most patients with stable chronic conditions. Evidence shows no meaningful difference in efficacy or safety, though psychological factors can affect perception. Cost savings are significant, and structured patient communication improves outcomes.

Recent-posts

Secnidazole in Pregnancy: What You Need to Know About Safety, Risks, and Alternatives

Oct, 28 2025

Ocular Hypertension Explained: Causes, Symptoms & Treatment Options

Sep, 24 2025

Lactose Intolerance: How to Get Diagnosed and Eat Without Pain

Jan, 6 2026

Insulin and Beta-Blockers: What You Need to Know About Hidden Hypoglycemia Risks

Dec, 11 2025

Decision Aids for Switching Medications: Understand the Risks and Benefits

Dec, 12 2025